Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells

  • Anja Reithmeier1,
  • Elena Panizza2,
  • Michael Krumpel1,
  • Lukas M. Orre2,
  • Rui M. M. Branca2,
  • Janne Lehtiö2,
  • Barbro Ek-Rylander1 and
  • Göran Andersson1Email author
Contributed equally
BMC Cancer201717:650

https://doi.org/10.1186/s12885-017-3616-7

Received: 27 June 2017

Accepted: 28 August 2017

Published: 15 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jun 2017 Submitted Original manuscript
27 Jul 2017 Reviewed Reviewer Report - Samuel Kerk
31 Jul 2017 Reviewed Reviewer Report - Margaritis Avgeris
22 Aug 2017 Author responded Author comments - Anja Reithmeier
Resubmission - Version 2
22 Aug 2017 Submitted Manuscript version 2
25 Aug 2017 Author responded Author comments - Anja Reithmeier
Resubmission - Version 3
25 Aug 2017 Submitted Manuscript version 3
Publishing
28 Aug 2017 Editorially accepted
15 Sep 2017 Article published 10.1186/s12885-017-3616-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Karolinska Institutet, Department of Laboratory Medicine (LABMED), H5, Division of Pathology, F46, Karolinska University Hospital
(2)
Karolinska Institutet, Department of Oncology-Pathology (OnkPat)

Advertisement